ACTIVE

CONTREL EUROPE

Export PDF

Financial year 2025 · closed on 30/12/2025

Net result

-206,5 k €

+3.5% YoY

Gross margin

250,7 k €

+20.0% YoY

Equity

-347,3 k €

-146.6% YoY

Workforce

8,0 ETP

+1.3% YoY

What does CONTREL EUROPE do?

CONTREL EUROPE is a Public limited company incorporated in 1984. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Gent. It employs on average 8,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0426.204.637

Incorporation

22/08/1984

Legal form

Public limited company

Registered office

Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map

Contributed capital

1 875 760,20 €

Latest accounts

30/12/2025

Average workforce

8,0 ETP

Activities (NACE)

32500Manufacture of medical and dental instruments and supplies· main 32500Manufacture of medical and dental instruments and supplies 33103Repair of fabricated metal products, machinery and equipment 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 32500Manufacture of medical and dental instruments and supplies+1

Joint committees (2)

Signals

Healthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2006
Income statement
Gross margin	250,7 k €	+20.0%	209 k €	-52.4%	439 k €	+78.7%	245,6 k €	+80.1%	136,3 k €	+87.1%	72,9 k €	-32.5%	107,9 k €	+272%	-62,6 k €	-238%	45,2 k €	-56.3%	103,5 k €	+98.8%	52,1 k €	-49.7%	103,6 k €	+59.3%	65 k €	+646%	-11,9 k €	-137%	32,4 k €	+109%	-358,2 k €	-42.7%	-251,1 k €	-111%	2,4 M €	+7.9%	2,2 M €
EBITDA	-165,3 k €	+2.1%	-168,7 k €	-401%	56 k €	+148%	-115,8 k €	+43.6%	-205,3 k €	+17.6%	-249,1 k €	-90.1%	-131 k €	+44.0%	-234,1 k €	-96.4%	-119,2 k €	-208%	-38,7 k €	+69.6%	-127,2 k €	-46.6%	-86,7 k €	+27.2%	-119,2 k €	+43.3%	-210,4 k €	+12.1%	-239,3 k €	+63.8%	-660,8 k €	-19.0%	-555,2 k €	-128%	2 M €	-7.9%	2,1 M €
Operating result	-207 k €	+3.3%	-214,2 k €	-2687%	8,3 k €	+105%	-159,4 k €	+36.3%	-250,3 k €	+13.8%	-290,3 k €	-67.0%	-173,9 k €	+32.5%	-257,7 k €	-73.9%	-148,2 k €	-140%	-61,9 k €	+54.5%	-136 k €	+4.7%	-142,7 k €	+22.1%	-183,2 k €	+36.2%	-287,3 k €	+20.5%	-361,6 k €	+52.7%	-765,2 k €	-19.2%	-641,8 k €	-135%	1,8 M €	-14.6%	2,1 M €
Net result	-206,5 k €	+3.5%	-214 k €	-2749%	8,1 k €	+104%	-184,6 k €	+26.4%	-251 k €	+13.8%	-291,1 k €	-67.0%	-174,3 k €	+31.3%	-253,7 k €	-72.3%	-147,3 k €	-1270%	-10,8 k €	-113%	83,5 k €	+406%	-27,3 k €	+88.4%	-234,6 k €	+18.6%	-288,2 k €	+10.6%	-322,5 k €	+53.3%	-691,1 k €	-34.7%	-513,2 k €	-136%	1,4 M €	-30.3%	2,1 M €
Balance sheet
Equity	-347,3 k €	-147%	-140,8 k €	-292%	73,2 k €	+12.4%	65,1 k €	-73.9%	249,7 k €	-50.1%	500,7 k €	-36.8%	791,8 k €	-18.0%	966,1 k €	-20.8%	1,2 M €	-10.8%	1,4 M €	-0.8%	1,4 M €	+6.4%	1,3 M €	-2.1%	1,3 M €	-15.1%	1,6 M €	-15.6%	1,8 M €	-14.9%	2,2 M €	-18.5%	2,7 M €	-16.2%	3,2 M €	+83.0%	1,7 M €
Total assets	467,9 k €	-22.6%	604,8 k €	-9.3%	667,1 k €	+25.8%	530,2 k €	-3.3%	548,1 k €	-23.0%	711,6 k €	-25.1%	950,6 k €	-10.0%	1,1 M €	-18.5%	1,3 M €	-8.8%	1,4 M €	-33.2%	2,1 M €	+6.6%	2 M €	+4.1%	1,9 M €	-7.0%	2,1 M €	-10.0%	2,3 M €	-8.0%	2,5 M €	-16.1%	3 M €	-15.2%	3,5 M €	+50.9%	2,3 M €
Cash	10,3 k €	+28.8%	8 k €	+1201%	612 €	-97.1%	21,4 k €	-21.1%	27,1 k €	-61.8%	70,9 k €	-43.8%	126,2 k €	-50.5%	254,9 k €	-22.1%	327,1 k €	-55.1%	729,1 k €	-60.8%	1,9 M €	+6.7%	1,7 M €	+7.4%	1,6 M €	-2.8%	1,7 M €	+0.2%	1,7 M €	+1.1%	1,6 M €	-28.0%	2,3 M €	-18.3%	2,8 M €	+35.9%	2,1 M €
Debts	815,1 k €	+9.3%	745,6 k €	+25.5%	594 k €	+27.7%	465,1 k €	+55.9%	298,4 k €	+41.5%	210,9 k €	+32.8%	158,8 k €	+76.9%	89,7 k €	+18.1%	76 k €	+40.2%	54,2 k €	-92.8%	748,4 k €	+6.9%	700,2 k €	+17.7%	595,1 k €	+20.8%	492,8 k €	+23.0%	400,7 k €	+35.7%	295,3 k €	+1.0%	292,5 k €	-8.0%	318 k €	-24.8%	423,1 k €
Other
Workforce	8,0 ETP	+1.3%	7,9 ETP	+3.9%	7,6 ETP	+2.7%	7,4 ETP	-1.3%	7,5 ETP	+13.6%	6,6 ETP	+15.8%	5,7 ETP	+39.0%	4,1 ETP	-6.8%	4,4 ETP	+12.8%	3,9 ETP	-2.5%	4,0 ETP	-18.4%	4,9 ETP	+6.5%	4,6 ETP	-4.2%	4,8 ETP	+4.3%	4,6 ETP	+43.7%	3,2 ETP	+3.2%	3,1 ETP	-8.8%	3,4 ETP	+112%	1,6 ETP

Governance

Board of directors

Seen on filing of 30/12/2025 · 2 active · 18 ended

Active mandates

Estate&Co

Director · 0837.628.553

Represented by Rina Werbrouck

Active

SOYIN

Director · 0838.827.393

Represented by Leander Sans

Active

Ended mandates

SOYIN

Director · since 08 janvier 2020 · 0838.827.393

Represented by Leander Sans

Ended

Bio Material Systems

Director · since 30 janvier 2013 · until 28 mai 2018 · 0441.296.253

Represented by Dirk Wildemeersch

Ended

Dirk Wildemeersch

Managing director · since 30 janvier 2013 · until 28 mai 2018

Ended

Hendrik Wildemeersch

Director · since 07 juin 2012 · until 30 décembre 2012

Ended

At this address

Other companies at this address

Company	CBE no.
Amalus Therapeutics● Bankrupt	0803.929.268
APCOR R&M● Active	0600.952.909
Ardoyen● Active	0875.102.821
AVROXA● Active	0687.774.936
Benebiose● Active	0784.521.548
BioNeering● Active	0807.194.309
CRODEON TECHNOLOGIES● Active	0642.754.761
Cryptobiotix● Active	0762.565.104
Gulliver Biomed● Active	0692.527.837
ImplicitMeasures.com● Bankrupt	0657.989.701
Inbiose● Active	0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active	0440.054.752
INNOVATIVE PHARMACEUTICS● Active	0883.574.582
Inspect● Active	0645.950.417
INVIBES ADVERTISING● Active	0836.533.938
KYTOS● Active	0768.755.286
Lares Solutions● Active	1015.346.906
MAYAKU PHARMACEUTICAL DEVELOPMENT● Active	0755.350.975
Microbial Resource Management Health● Active	0742.910.132
Microbial Resource Management Technologies● Active	0667.765.816

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Closing of the financial year	30/12/2025	30/12/2024	30/12/2023	30/12/2022	30/12/2021	30/12/2020
Length of the financial year	13 months	13 months	13 months	13 months	13 months	13 months
Filing date	24/07/2026	23/07/2025	31/07/2024	28/07/2023	27/08/2022	30/07/2021
General meeting	09/07/2026	17/07/2025	27/05/2024	12/07/2023	22/07/2022	07/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/12/2025	09/07/2026	24/07/2026	Dutch	PDF
Abridged model	30/12/2024	17/07/2025	23/07/2025	Dutch	PDF
Abridged model	30/12/2023	27/05/2024	31/07/2024	Dutch	PDF
Abridged model	30/12/2022	12/07/2023	28/07/2023	Dutch	PDF
Abridged model	30/12/2021	22/07/2022	27/08/2022	Dutch	PDF
Abridged model	30/12/2020	07/07/2021	30/07/2021	Dutch	PDF
Abridged model	30/12/2019	25/05/2020	31/08/2020	Dutch	PDF
Abridged model	30/12/2018	27/05/2019	02/07/2019	Dutch	PDF
Abridged model	30/12/2017	28/05/2018	02/07/2018	Dutch	PDF
Abridged model	30/12/2016	27/06/2017	30/06/2017	Dutch	PDF
Abridged model	30/12/2015	30/05/2016	30/06/2016	Dutch	PDF
Abridged model	30/12/2014	03/07/2015	08/07/2015	Dutch	PDF
Abridged model	30/12/2013	09/09/2014	15/09/2014	Dutch	PDF
Abridged model	30/12/2012	25/09/2013	30/09/2013	Dutch	PDF
Abridged model	30/12/2011	30/01/2013	04/02/2013	Dutch	PDF
Abridged model	30/12/2010	15/06/2011	22/06/2011	Dutch	PDF
Abridged model	30/12/2009	08/09/2010	13/09/2010	Dutch	PDF
Abridged model	30/12/2008	25/05/2009	18/12/2009	Dutch	PDF
Abridged model	31/12/2006	28/05/2007	03/09/2007	Dutch	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/12/2025 · 2 active · 18 ended

Active mandates

Estate&Co

Director · 0837.628.553

Represented by Rina Werbrouck

Active

SOYIN

Director · 0838.827.393

Represented by Leander Sans

Active

Ended mandates

SOYIN

Director · since 08 janvier 2020 · 0838.827.393

Represented by Leander Sans

Ended

Bio Material Systems

Director · since 30 janvier 2013 · until 28 mai 2018 · 0441.296.253

Represented by Dirk Wildemeersch

Ended

Dirk Wildemeersch

Managing director · since 30 janvier 2013 · until 28 mai 2018

Ended

Hendrik Wildemeersch

Director · since 07 juin 2012 · until 30 décembre 2012

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates31/01/2020
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/12/2018
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/03/2013
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares01/03/2010
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates01/02/2010
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/04/2008
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares31/12/2007
BOEKJAAR - ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Registered office16/10/2007
MAATSCHAPPELIJKE ZETEL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-206,5 k €↑
2024
Annual accounts 2024-214 k €↓
2023
Annual accounts 20238,1 k €↑
2022
Annual accounts 2022-184,6 k €↑
2021
Annual accounts 2021-251 k €↑
2020
Annual accounts 2020-291,1 k €↓
2019
Annual accounts 2019-174,3 k €↑
2018
Annual accounts 2018-253,7 k €↓
2017
Annual accounts 2017-147,3 k €↓
2016
Annual accounts 2016-10,8 k €↓
2015
Annual accounts 201583,5 k €↑
2014
Annual accounts 2014-27,3 k €↑
2013
Annual accounts 2013-234,6 k €↑
2012
Annual accounts 2012-288,2 k €↑
2011
Annual accounts 2011-322,5 k €↑
2010
Annual accounts 2010-691,1 k €↓
2009
Annual accounts 2009-513,2 k €↓
2008
Annual accounts 20081,4 M €↓
2006
Annual accounts 20062,1 M €
22/08/1984
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

CONTREL EUROPE

Overview

What does CONTREL EUROPE do?

Trend over 19 financial years

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline